Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Cannabidiol Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?
The scale of the cannabidiol market has expanded significantly over the past few years. This market is projected to expand from $15.44 billion in 2025 to reach $20.34 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 31.7%. Historically, this expansion has been driven by factors such as the legalization of medical cannabis in important areas, an increase in the adoption of alternative medicine, growing consumer understanding of CBD’s advantages, the broadening of hemp farming, and the accessibility of CBD extraction methods.
The cannabidiol market is projected to experience rapid expansion over the upcoming years. Its valuation is anticipated to reach $62.61 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 32.5%. This growth during the projected period stems from factors such as broader acceptance of CBD within healthcare, escalating investments in cannabinoid research, the proliferation of regulated CBD retail channels, a heightened demand for plant-derived therapeutics, and greater standardization of CBD formulations. Significant trends expected in the forecast period encompass the increasing integration of CBD-based therapeutics, a surge in demand for wellness and nutraceutical offerings, expanded application in personal care formulations, the widening availability of pharmaceutical-grade CBD products, and a stronger emphasis on adherence to regulatory standards.
Get A Free Sample Report With In-Depth Market Insights:
Cannabidiol Market Demand Drivers Opening New Revenue Streams
The growing occurrence of neurological conditions is anticipated to drive expansion in the cannabidiol market moving forward. Neurological disorders are health issues that impact the central and peripheral nervous systems, encompassing the brain, spinal cord, and the body’s nerves. Cannabis offers therapeutic benefits for these neurological conditions by regulating calcium homeostasis and reducing neuroinflammation. As an illustration, the Alzheimer’s Association, a US-based nonprofit voluntary health organization, reported in March 2023 that approximately 6.7 million Americans aged 65 and older were afflicted with Alzheimer’s dementia in 2023. This figure is predicted to increase to 13.8 million by 2060. Consequently, the rising incidence of neurological disorders is fueling the expansion of the cannabidiol market.
Cannabidiol Market Segment Analysis: What Are The Core Market Categories?
The cannabidiol market covered in this report is segmented –
1) By Product: Oil, Tinctures, Suppository, Transdermal Patches, Vape Oil, Isolates, Creams and Roll-on, Capsules, Tablet, Other Products
2) By Source: Marijuana, Hemp
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Stores, Other Distribution Channels
4) By Application: Medical, Personal Use, Pharmaceuticals, Wellness
Subsegments:
1) By Oil: Full-Spectrum CBD Oil, Broad-Spectrum CBD Oil, CBD Isolate Oil
2) By Tinctures: CBD Tinctures with Flavoring, Unflavored CBD Tinctures
3) By Suppository: Rectal Suppositories, Vaginal Suppositories
4) By Transdermal Patches: CBD Patches for Pain Relief, CBD Patches for Sleep
5) By Vape Oil: CBD Vape Cartridges, CBD Vape Juice
6) By Isolates: CBD Powder, CBD Crystals
7) By Creams and Roll-on: Topical CBD Creams, CBD Roll-on Gels
8) By Capsules: Softgel Capsules, Hard Capsules
9) By Tablet: CBD Tablets, CBD Chewable Tablets
10) By Other Products: Gummies, Beverages, Edibles
Cannabidiol Market Trends Powering Strategic Industry Growth
Major companies within the cannabidiol market are prioritizing the development of innovative products, such as epilepsy therapeutic launches to enhance the management of seizures. An epilepsy therapeutic launch signifies the official introduction or market entry of a pharmaceutical drug specifically formulated to prevent, control, or treat epilepsy, with the goal of improving seizure management and patient outcomes. For example, in January 2024, Akumentis Healthcare Ltd., an India-based pharmaceutical manufacturing company, introduced Clasepi for epilepsy treatment. A new DCGI-approved prescription cannabidiol has been released in India to assist in managing seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and Tuberous Sclerosis Complex in patients aged one year and older. This synthetic CBD product contains less than 0.1% THC, guaranteeing its non-psychotropic nature. Clinical studies indicate its efficacy in reducing seizures, especially when traditional antiseizure medications are ineffective.
Cannabidiol Market Top Companies Driving Competitive Growth
Major companies operating in the cannabidiol market are Endoca BV, Cannoid LLC, Medical Marijuana Inc., Folium Biosciences, Elixinol Global Limited, NuLeaf Naturals LLC, Isodiol International Inc., Pharmahemp d.o.o., Canopy Growth Corp., CV Sciences Inc., Medterra LLC, Cronos Group, CBD American Shaman LLC, Aphria Inc., Maricann Inc., Tilray Inc., Organigram Holding Inc., CannTrust Holdings Company, Charlotte’s Web Holdings Inc., Aurora Cannabis Inc., GW Pharmaceuticals PLC, Green Roads, HempMeds PX LLC, Eco Sciences, Bluebird Botanicals, HempFusion Inc., Kannaway LLC, Lazarus Naturals, Kazmira LLC, HempLife Today LLC
View The Full Cannabidiol Market Report:
Cannabidiol Market Global Footprint: Which Region Leads The Industry?
North America was the largest region in the cannabidiol market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cannabidiol market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
